RXO Statements
RX
RXO Income Statement
B
M
USD (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
978
100
799
81.7
179
18.3
—
0
146
14.9
161
16.5
18
1.8
-8
-0.8
-2
-0.2
4
0.4
2
0.2
2
0.2
0.017
119.58
976
100
801
82.1
175
17.9
—
0
148
15.2
164
16.8
11
1.1
-8
-0.8
-1
-0.1
-3
-0.3
-2
-0.2
-1
-0.1
-0.01
117
963
100
782
81.2
181
18.8
—
0
144
15
162
16.8
19
2
-8
-0.8
—
0
6
0.6
3
0.3
3
0.3
0.03
119.5
1 010
100
820
81.2
190
18.8
—
0
153
15.1
171
16.9
19
1.9
-8
-0.8
—
0
-3
-0.3
-3
-0.3
—
0
—
119.4
1 120
100
901
80.4
219
19.6
—
0
155
13.8
176
15.7
43
3.8
-5
-0.4
—
0
-6
-0.5
-2
-0.2
-4
-0.4
-0.03
116.3
1 138
100
913
80.2
225
19.8
—
0
158
13.9
181
15.9
44
3.9
1
0.09
-1
-0.09
15
1.3
2
0.2
13
1.1
0.11
115
1 226
100
960
78.3
266
21.7
—
0
166
13.5
187
15.3
79
6.4
—
0
1
0.08
59
4.8
15
1.2
44
3.6
0.38
115.1
1 312
100
1 076
82
236
18
—
0
161
12.3
182
13.9
54
4.1
—
0
—
0
51
3.9
12
0.9
39
3
0.34
115.1